Search Login Register

Acarbose Summary

Description: An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. (From Martindale The Extra Pharmacopoeia, 31st ed)

Also Known As: Bay g 5421; Bayer Brand of Acarbose; Glucobay; Glucor; Glumida Show All >>

Networked: 549 relevant articles (101 outcomes, 153 trials/studies) for this Drug

Key Diseases for which Acarbose is Relevant

  1. Type 2 Diabetes Mellitus (MODY) : 34 outcomes 78 studies in 179 results
  2. Hyperglycemia : 14 outcomes 7 studies in 84 results
  3. Diabetes Mellitus : 9 outcomes 12 studies in 66 results
  4. Body Weight (Weight, Body) : 6 outcomes 7 studies in 54 results
  5. Insulin Resistance : 5 outcomes 7 studies in 36 results
Show All >>

Drugs Related to Acarbose

  1. Metformin (Glucophage)
  2. Glucose (Dextrose)
  3. alpha-Glucosidases (Acid Maltase)
  4. Insulin (Novolin)
  5. Acarbose
  6. Blood Glucose (Blood Sugar)
  7. nateglinide (Starlix)
  8. Glucosidases
  9. Hypoglycemic Agents (Hypoglycemics)
  10. Thiazolidinediones
Show All >>

Therapies Related to Acarbose

  1. Long-Term Care
  2. Drug Therapy (Chemotherapy)
  3. Fundoplication
  4. Exercise Therapy (Therapy, Exercise)
  5. Oral Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.